Latest Insider Transactions at Medpace Holdings, Inc. (MEDP)
This section provides a real-time view of insider transactions for Medpace Holdings, Inc. (MEDP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Medpace Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Medpace Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 22
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
14,377
-0.23%
|
$2,702,876
$188.64 P/Share
|
|
Apr 21
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
15,687
-0.25%
|
$2,933,469
$187.02 P/Share
|
|
Apr 21
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
15,687
-0.25%
|
$2,933,469
$187.02 P/Share
|
|
Apr 20
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
17,623
-0.28%
|
$3,207,386
$182.44 P/Share
|
|
Apr 20
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
17,623
-0.28%
|
$3,207,386
$182.44 P/Share
|
|
Apr 19
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
8,471
-0.13%
|
$1,524,780
$180.9 P/Share
|
|
Apr 19
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
8,471
-0.13%
|
$1,524,780
$180.9 P/Share
|
|
Apr 16
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
17,528
-0.27%
|
$3,155,040
$180.3 P/Share
|
|
Apr 16
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
17,528
-0.27%
|
$3,155,040
$180.3 P/Share
|
|
Apr 15
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
31,270
-0.48%
|
$5,816,220
$186.65 P/Share
|
|
Apr 15
2021
|
Stephen P Ewald General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
3,800
-21.52%
|
$703,000
$185.18 P/Share
|
|
Apr 15
2021
|
Stephen P Ewald General Counsel & Corp. Secy. |
BUY
Exercise of conversion of derivative security
|
Direct |
3,800
+17.71%
|
$106,400
$28.32 P/Share
|
|
Apr 15
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
31,270
-0.48%
|
$5,816,220
$186.65 P/Share
|
|
Apr 14
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
3,720
-0.06%
|
$669,600
$180.48 P/Share
|
|
Apr 14
2021
|
Jesse J Geiger President |
SELL
Open market or private sale
|
Direct |
3,000
-31.98%
|
$540,000
$180.0 P/Share
|
|
Apr 14
2021
|
Jesse J Geiger President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+24.23%
|
$84,000
$28.32 P/Share
|
|
Apr 14
2021
|
Stephen P Ewald General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
1,200
-7.97%
|
$216,000
$180.67 P/Share
|
|
Apr 14
2021
|
Stephen P Ewald General Counsel & Corp. Secy. |
BUY
Exercise of conversion of derivative security
|
Direct |
1,200
+7.38%
|
$33,600
$28.32 P/Share
|
|
Apr 14
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
3,720
-0.06%
|
$669,600
$180.48 P/Share
|
|
Mar 03
2021
|
Susan E Burwig Exec. VP, Operations |
SELL
Open market or private sale
|
Direct |
6,211
-8.15%
|
$1,037,237
$167.0 P/Share
|
|
Feb 10
2021
|
Jesse J Geiger President |
SELL
Open market or private sale
|
Direct |
4,000
-38.53%
|
$640,000
$160.0 P/Share
|
|
Feb 10
2021
|
Jesse J Geiger President |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+27.81%
|
$92,000
$23.0 P/Share
|
|
Feb 09
2021
|
Stephen P Ewald General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
10,000
-41.92%
|
$1,550,000
$155.48 P/Share
|
|
Feb 09
2021
|
Stephen P Ewald General Counsel & Corp. Secy. |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+29.54%
|
$900,000
$90.65 P/Share
|
|
Jan 08
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
26,666
-0.41%
|
$3,733,240
$140.71 P/Share
|
|
Jan 08
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
26,666
-0.41%
|
$3,733,240
$140.71 P/Share
|
|
Jan 07
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
93,552
-1.42%
|
$13,097,280
$140.06 P/Share
|
|
Jan 07
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
93,552
-1.42%
|
$13,097,280
$140.06 P/Share
|
|
Jan 06
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
91,667
-1.37%
|
$12,833,380
$140.06 P/Share
|
|
Jan 06
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
91,667
-1.37%
|
$12,833,380
$140.06 P/Share
|
|
Jan 06
2021
|
August J. Troendle CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
185,347
+0.55%
|
$2,965,552
$16.03 P/Share
|
|
Jan 06
2021
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Direct |
185,347
+0.55%
|
$2,965,552
$16.03 P/Share
|
|
Jan 04
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
10,127
-0.16%
|
$1,417,780
$140.01 P/Share
|
|
Jan 04
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,127
-0.16%
|
$1,417,780
$140.01 P/Share
|
|
Dec 30
2020
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
19,930
-0.31%
|
$2,790,200
$140.01 P/Share
|
|
Dec 30
2020
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
19,930
-0.31%
|
$2,790,200
$140.01 P/Share
|
|
Dec 28
2020
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,374
-0.02%
|
$192,360
$140.0 P/Share
|
|
Dec 28
2020
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
1,374
-0.02%
|
$192,360
$140.0 P/Share
|
|
Dec 24
2020
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
3,829
-0.06%
|
$536,060
$140.0 P/Share
|
|
Dec 24
2020
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
3,829
-0.06%
|
$536,060
$140.0 P/Share
|
|
Dec 23
2020
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
3,547
-0.05%
|
$496,580
$140.11 P/Share
|
|
Dec 23
2020
|
August J. Troendle CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+5.36%
|
$2,160,000
$54.74 P/Share
|
|
Dec 23
2020
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
3,547
-0.05%
|
$496,580
$140.11 P/Share
|
|
Dec 22
2020
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
33,260
-0.51%
|
$4,656,400
$140.01 P/Share
|
|
Dec 22
2020
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
33,260
-0.51%
|
$4,656,400
$140.01 P/Share
|
|
Dec 18
2020
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
216,048
-3.19%
|
$30,462,768
$141.85 P/Share
|
|
Dec 18
2020
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
216,048
-3.19%
|
$30,462,768
$141.85 P/Share
|
|
Dec 14
2020
|
Jesse J Geiger President |
SELL
Open market or private sale
|
Direct |
4,200
-39.69%
|
$596,400
$142.0 P/Share
|
|
Dec 14
2020
|
Jesse J Geiger President |
BUY
Exercise of conversion of derivative security
|
Direct |
4,200
+28.41%
|
$96,600
$23.0 P/Share
|
|
Dec 10
2020
|
Stephen P Ewald General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
10,000
-41.92%
|
$1,400,000
$140.07 P/Share
|